Biofrontera AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0006046113
EUR
2.42
-0.46 (-15.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Merck KGaA
Dermapharm Holding SE
PharmaSGP Holding SE
Bayer AG
Heidelberg Pharma AG
Formycon AG
Evotec SE
PAION AG
Haemato AG
APONTIS PHARMA AG
Biofrontera AG

Why is Biofrontera AG ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found
Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-6.78%
EBIT Growth (5y)
14.52%
EBIT to Interest (avg)
-2.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
1.07
Tax Ratio
55.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.45%
ROCE (avg)
7.72%
ROE (avg)
11.71%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.87
EV to EBIT
-2.32
EV to EBITDA
-2.70
EV to Capital Employed
0.85
EV to Sales
0.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-36.76%
ROE (Latest)
-23.07%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend

Here's what is working for Biofrontera AG

Net Sales - Half Yearly
At EUR 14.47 MM has Grown at 35.67 %
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (EUR MM)

Profit After Tax (PAT) - Quarterly
At EUR 6 MM has Grown at 375.0 %
over average PAT of the previous four periods of EUR -2 MM
MOJO Watch
Near term PAT trend is very positive

PAT (EUR MM)

Profit After Tax (PAT) - Quarterly
Highest at EUR 6 MM.
in the last five periods
MOJO Watch
Near term PAT trend is positive

PAT (EUR MM)

Earnings per Share (EPS) - Quarterly
Highest at EUR 0.09
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (EUR)

Inventory Turnover Ratio- Half Yearly
Highest at 6.35 times
in the last five half yearly periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio- Half Yearly
Highest at 41.67 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio